Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites

M Abbattista, I Martinelli… - Journal of Thrombosis and …, 2021 - Wiley Online Library
Background Real‐world experience with adenoviral vector vaccines against COVID‐19
raised some safety concerns. Cases of cerebral vein thrombosis (CVT) associated with …

Thrombotic adverse events reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the …

M Tobaiqy, K MacLure, H Elkout, D Stewart - Vaccines, 2021 - mdpi.com
Vaccination against COVID-19 is the cornerstone of controlling and mitigating the ongoing
pandemic. Thrombotic adverse events linked to Moderna, Pfizer and the Oxford …

Analysis of thrombotic adverse reactions of COVID-19 AstraZeneca vaccine reported to EudraVigilance database

M Tobaiqy, H Elkout, K MacLure - Vaccines, 2021 - mdpi.com
The development of safe, effective, affordable vaccines against COVID-19 remains the
cornerstone to mitigating this pandemic. Early in December 2020, multiple research groups …

Spontaneous reporting to regulatory authorities of suspected adverse drug reactions to COVID-19 vaccines over time: the effect of publicity

RE Ferner, RJ Stevens, C Anton, JK Aronson - Drug Safety, 2022 - Springer
Abstract Introduction The UK Medicines and Healthcare products Regulatory Agency
(MHRA) has published frequent summaries of spontaneous reports of suspected adverse …

Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us–and what they don't

SV Konstantinides - European Respiratory Journal, 2021 - Eur Respiratory Soc
In the present issue of the European Respiratory Journal, Smadja et al.[1] present an
analysis of global pharmacovigilance reports of thrombotic events following severe acute …

Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination

J Douxfils, J Favresse, JM Dogné, T Lecompte… - Thrombosis research, 2021 - Elsevier
As of 4 April 2021, a total of 169 cases of cerebral venous sinus thrombosis (CVST) and 53
cases of splanchnic vein thrombosis were reported to EudraVigilance among around 34 …

Description of frequencies of reported adverse events following immunization among four different COVID-19 vaccine brands

A Kant, J Jansen, L van Balveren, F van Hunsel - Drug safety, 2022 - Springer
Introduction The rapid rollout of coronavirus disease 2019 (COVID-19) vaccines for a large
proportion of the population necessitates a strong emphasis on safety. Complementary to …

Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)

LCA Esba, M Al Jeraisy - Expert Review of Vaccines, 2021 - Taylor & Francis
Objectives: Several cases of unusual thrombotic events with thrombocytopenia were
reported in several countries, in association with AstraZeneca's COVID-19 vaccine. The …

[HTML][HTML] Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases-an ACCESS cohort study

C Willame, C Dodd, CE Durán, R Elbers, R Gini… - Vaccine, 2023 - Elsevier
Abstract Background In May 2020, the ACCESS (The vACCine covid-19 monitoring
readinESS) project was launched to prepare real-world monitoring of COVID-19 vaccines …

CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals

HA Merchant - Journal of pharmaceutical policy and practice, 2021 - Springer
There have been recent reports of haemorrhage, blood clots and thrombocytopenia
following administration of CoViD-19 vaccines that have raised concerns over the safety of …